pyrroles has been researched along with Pheochromocytoma in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 16 (76.19) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullova, P; Cougnoux, A; Kopacek, J; Marzouca, G; Pacak, K | 1 |
| Bergman, PJ; Johannes, CM; Musser, ML; Taikowski, KL | 1 |
| Kowalewicz-Kulbat, M; Lawnicka, H; Melen-Mucha, G; Motylewska, E; Niedziela, A; Sicinska, P; Stepien, H | 1 |
| Asa, SL; Cassol, CA; Ezzat, S; Guo, M; Liu, W; Winer, D | 1 |
| Akaihata, H; Haga, N; Hata, J; Ishibashi, K; Kataoka, M; Koguchi, T; Kojima, Y; Ogawa, S; Satoh, Y; Takahashi, N | 1 |
| Anouar, Y; Baudin, E; Denorme, M; Dubessy, C; Gonzalez, BJ; Roux, C; Yon, L | 1 |
| Cai, X; Liu, J; Luo, J; Song, Y; Wang, L; Xu, H; Xu, S; Zhang, S | 1 |
| Bobrzyk, M; Chronowska, J; Kukla, U; Madej, P; Okopień, B; Łabuzek, K | 1 |
| Makis, W; McCann, K; McEwan, AJ; Sawyer, MB | 1 |
| Bachmann, M; Bergmann, R; Block, NL; Bornstein, SR; Cartellieri, M; Ehrhart-Bornstein, M; Eisenhofer, G; Peitzsch, M; Pietzsch, J; Schally, AV; Ullrich, M; Zenker, EF; Ziegler, CG | 1 |
| Asa, SL; Broom, R; Evans, A; Ezzat, S; Freeman, M; Joshua, AM; Knox, JJ | 1 |
| Cabanillas, ME; Jimenez, C; Jonasch, E; Kyle, KL; Lano, EA; Matin, SF; Nunez, RF; Perrier, ND; Phan, A; Rich, TA; Santarpia, L; Shah, B; Waguespack, SG; Williams, MD | 1 |
| Ahn, H; Ahn, JH; Choi, JS; Kim, TW; Kim, YR; Koh, JM; Lee, DH; Lee, JL; Lee, JS; Park, I; Park, KS; Park, TS | 1 |
| Miura, T; Nemoto, K; Shioji, G; Tsuboi, N | 1 |
| Dai, J; He, HC; Huang, X; Shen, ZJ; Su, TW; Sun, FK; Zhou, WL | 1 |
| Aita, Y; Hara, H; Ikeda, T; Ishii, KA; Kawakami, Y; Saito, Y; Shimano, H; Takekoshi, K | 1 |
| Al Ghuzlan, A; Anderson, P; Ayala-Ramirez, M; Baudin, E; Cabanillas, ME; Caramella, C; Chougnet, CN; Deandreis, D; Habra, MA; Jimenez, C; Leboulleux, S; Palmer, JL; Waguespack, SG | 1 |
| Bergmann, R; Bornstein, SR; Ehrhart-Bornstein, M; Eisenhofer, G; Gebauer, L; Gondek, K; Pacak, K; Pietzsch, J; Qin, N; Schally, AV; Ullrich, M; Ziegler, CG | 1 |
| Hara, H; Ikeda, T; Ishii, KA; Kawakami, Y; Miura, M; Otagiri, A; Saito, Y; Shimano, H; Takekoshi, K | 1 |
| Fukuda, T; Ishii, K; Isobe, K; Kawakami, Y; Nanmoku, T; Takekoshi, K | 1 |
| Schein, PS | 1 |
1 review(s) available for pyrroles and Pheochromocytoma
| Article | Year |
|---|---|
Chemotherapeutic management of the hormone-secreting endocrine malignancies.
Topics: Adenoma, Islet Cell; Adrenal Gland Neoplasms; Aminoglutethimide; Aniline Compounds; Antibiotics, Antineoplastic; Antineoplastic Agents; Butanones; Carcinoid Tumor; Diazoxide; Humans; Hypoglycemia; Insulin Antagonists; Kidney Tubules; Metyrapone; Mitotane; Neoplasm Metastasis; Pheochromocytoma; Pyrimidines; Pyrroles; Pyrrolidines; Ribonucleosides; Serotonin Antagonists; Streptozocin | 1972 |
20 other study(ies) available for pyrroles and Pheochromocytoma
| Article | Year |
|---|---|
Bortezomib Alone and in Combination With Salinosporamid A Induces Apoptosis and Promotes Pheochromocytoma Cell Death In Vitro and in Female Nude Mice.
Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bortezomib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Lactones; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Pheochromocytoma; Proteasome Inhibitors; Pyrroles | 2017 |
Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017).
Topics: Adrenal Gland Neoplasms; Animals; Dog Diseases; Dogs; Female; Indoles; Male; Pheochromocytoma; Pyrroles; Retrospective Studies; Treatment Outcome | 2018 |
Interferon alpha and rapamycin inhibit the growth of pheochromocytoma PC12 line in vitro.
Topics: Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Proliferation; Endostatins; Growth Hormone-Releasing Hormone; Indoles; Interferon-alpha; Neovascularization, Pathologic; PC12 Cells; Pheochromocytoma; Pyrroles; Rats; Sirolimus; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2013 |
Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas.
Topics: Adrenal Gland Neoplasms; Adult; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Drug Design; Female; Humans; Immunohistochemistry; Indoles; Male; Mice; Middle Aged; Molecular Targeted Therapy; Mutation; Paraganglioma; Pheochromocytoma; Polymorphism, Single Nucleotide; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Succinate Dehydrogenase; Sunitinib; Tissue Array Analysis | 2014 |
Sunitinib for refractory malignant pheochromocytoma: two case reports.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Humans; Immunohistochemistry; Indoles; Liver Neoplasms; Male; Middle Aged; Pheochromocytoma; Pyrroles; Sunitinib; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A; Young Adult | 2014 |
Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
Topics: Administration, Oral; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Heterografts; Indoles; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Niacinamide; PC12 Cells; Phenylurea Compounds; Pheochromocytoma; Protein Kinase Inhibitors; Pyrroles; Rats; Sorafenib; Sunitinib; Time Factors; Tumor Burden | 2014 |
Carbon fiber ultramicrodic electrode electrodeposited with over-oxidized polypyrrole for amperometric detection of vesicular exocytosis from pheochromocytoma cell.
Topics: Adrenal Gland Neoplasms; Animals; Carbon; Carbon Fiber; Dopamine; Electrochemical Techniques; Electrodes; Electroplating; Exocytosis; Oxidation-Reduction; Pheochromocytoma; Polymers; Pyrroles; Rats; Signal-To-Noise Ratio; Time Factors; Transport Vesicles | 2015 |
[Antiangiogenic therapy of malignant pheochromocytoma and paraganglioma with the view to the recent scientific developments].
Topics: Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Benzamides; Humans; Imatinib Mesylate; Indoles; Neovascularization, Pathologic; Paraganglioma; Pheochromocytoma; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sunitinib; Thalidomide | 2015 |
Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Chemoradiotherapy; Female; Humans; Indoles; Mutation; Pheochromocytoma; Pyrroles; Remission Induction; Succinate Dehydrogenase; Sunitinib | 2016 |
Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Doxorubicin; Mice; Octreotide; Peptides, Cyclic; Pheochromocytoma; Pyrroles; Radiopharmaceuticals; Receptors, Somatostatin; Theranostic Nanomedicine; Treatment Outcome | 2016 |
Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Agents; Humans; Indoles; Male; Middle Aged; Mutation; Paraganglioma; Pheochromocytoma; Pyrroles; Sunitinib; Tomography, X-Ray Computed | 2009 |
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
Topics: Adrenal Gland Neoplasms; Adult; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Drug Delivery Systems; Female; Humans; Indoles; Neoplasms, Multiple Primary; Pheochromocytoma; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Treatment Outcome; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 2009 |
Sunitinib, a novel therapy for anthracycline- and cisplatin-refractory malignant pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Humans; Indoles; Liver Neoplasms; Male; Mediastinal Neoplasms; Pheochromocytoma; Pyrroles; Sunitinib | 2009 |
Sunitinib treatment for refractory malignant pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Agents; Drug Resistance, Neoplasm; Fatal Outcome; Female; Humans; Indoles; Pheochromocytoma; Pyrroles; Radiography; Radionuclide Imaging; Sunitinib; Treatment Outcome | 2012 |
Multi-targeted tyrosine kinase inhibitor sunitinib: a novel strategy for sporadic malignant pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Female; Humans; Indoles; Male; Middle Aged; Pheochromocytoma; Protein Kinase Inhibitors; Pyrroles; Sunitinib | 2012 |
Sunitinib inhibits catecholamine synthesis and secretion in pheochromocytoma tumor cells by blocking VEGF receptor 2 via PLC-γ-related pathways.
Topics: Angiogenesis Inhibitors; Animals; Blotting, Western; Catecholamines; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Humans; Indoles; Inositol 1,4,5-Trisphosphate; PC12 Cells; Pheochromocytoma; Phospholipase C gamma; Protein Kinase C; Pyrroles; Rats; Receptors, Vascular Endothelial Growth Factor; RNA, Small Interfering; Signal Transduction; Sunitinib; Tyrosine 3-Monooxygenase | 2012 |
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Indoles; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Pyrroles; Retrospective Studies; Sunitinib; Treatment Outcome | 2012 |
Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells.
Topics: 2-Hydroxyphenethylamine; Adrenal Gland Neoplasms; Aniline Compounds; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Gonadotropin-Releasing Hormone; Growth Hormone-Releasing Hormone; Mice; Pheochromocytoma; Pyrroles; Receptors, LHRH; Receptors, Neuropeptide; Receptors, Pituitary Hormone-Regulating Hormone; Receptors, Somatostatin; Sermorelin; Somatostatin | 2013 |
Inhibition of autophagy enhances sunitinib-induced cytotoxicity in rat pheochromocytoma PC12 cells.
Topics: Adaptor Proteins, Signal Transducing; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Autophagy; Autophagy-Related Proteins; Indoles; Mechanistic Target of Rapamycin Complex 1; Microtubule-Associated Proteins; Molecular Targeted Therapy; Multiprotein Complexes; PC12 Cells; Pheochromocytoma; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proteins; Pyrroles; Rats; Signal Transduction; Sunitinib; TOR Serine-Threonine Kinases | 2013 |
Stimulation of catecholamine biosynthesis via the PKC pathway by prolactin-releasing peptide in PC12 rat pheochromocytoma cells.
Topics: Animals; Catecholamines; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Flavonoids; Hypothalamic Hormones; Indoles; Isoquinolines; MAP Kinase Signaling System; Neuropeptides; Pheochromocytoma; Prolactin-Releasing Hormone; Protein Kinase C; Pyrroles; Rats; RNA, Messenger; Signal Transduction; Stimulation, Chemical; Sulfonamides; Tyrosine 3-Monooxygenase | 2005 |